Journal articleHuman

Objective light exposure measurements and circadian rhythm in patients with erythropoietic protoporphyria: A case-control study

Molecular genetics and metabolism, 2022 Mar. Wensink D, Wagenmakers MAEM, Qi H and 2 others.

Study type

Journal article

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Molecular genetics and metabolism

Published

2022 Mar

PubMed

PMID 35034844 ↗

DOI

10.1016/j.ymgme.2021.12.017 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Afamelanotide →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdultCase-Control StudiesCircadian RhythmDermatitis, PhototoxicHumansPainProtoporphyria, Erythropoietic

Other papers on Afamelanotide

Randomized controlled trial · 2015

Afamelanotide for Erythropoietic Protoporphyria

Review · 2019

Eruptive Melanocytic Nevi: A Review

Review · 2017

Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page